Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Let’s cure childhood cancer. Together.
Science & medicine news
-
Control of rhabdomyosarcoma cell identity provides clues to possible treatments
Findings from St. Jude Children’s Research Hospital show how control of transcription factors by a common tumor suppressor gene may provide a therapeutic opportunity in a type of childhood cancer.
-
Research reveals new treatment strategy for propionic acidemia
Findings from St. Jude Children’s Research Hospital shed light on what drives this metabolic disease and provides clues to targeted treatment with pantazines.
-
Research provides evidence for how a key transcription factor manages access to DNA
St. Jude scientists have revealed a previously unknown role for CTCF, a pivotal transcription regulator linked to cancer.
-
The PANoptosome: a new frontier in innate immune responses
St. Jude scientists detail how inflammasomes act as integral components of mega-cell death complexes called PANoptosomes for host defense in live viral and bacterial infections.
-
St. Jude and leading cancer centers urge vaccination to protect against HPV and other diseases
NCI-designated cancer centers, AACI members and other cancer centers and medical groups endorse HPV vaccination and cancer screening to eliminate cancers caused by the virus.
-
COVID-19 in children with cancer: Severe disease and disrupted treatment
Scientists from St. Jude and the International Society of Paediatric Oncology report results from the Global Registry of COVID-19 and Childhood Cancer.